Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs JUBILANT PHARMOVA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES JUBILANT PHARMOVA DIVIS LABORATORIES/
JUBILANT PHARMOVA
 
P/E (TTM) x 66.0 -2,647.7 - View Chart
P/BV x 7.1 1.7 425.6% View Chart
Dividend Yield % 0.9 0.9 99.3%  

Financials

 DIVIS LABORATORIES   JUBILANT PHARMOVA
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-23
JUBILANT PHARMOVA
Mar-23
DIVIS LABORATORIES/
JUBILANT PHARMOVA
5-Yr Chart
Click to enlarge
High Rs4,641496 936.5%   
Low Rs2,730269 1,015.6%   
Sales per share (Unadj.) Rs292.6394.4 74.2%  
Earnings per share (Unadj.) Rs68.7-4.1 -1,686.2%  
Cash flow per share (Unadj.) Rs81.630.7 265.8%  
Dividends per share (Unadj.) Rs30.005.00 600.0%  
Avg Dividend yield %0.81.3 62.2%  
Book value per share (Unadj.) Rs480.9338.6 142.0%  
Shares outstanding (eoy) m265.47159.28 166.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x12.61.0 1,299.8%   
Avg P/E ratio x53.7-93.8 -57.2%  
P/CF ratio (eoy) x45.212.4 362.9%  
Price / Book Value ratio x7.71.1 678.9%  
Dividend payout %43.7-122.7 -35.6%   
Avg Mkt Cap Rs m978,37860,873 1,607.2%   
No. of employees `000NANA-   
Total wages/salary Rs m9,75021,660 45.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m77,67562,817 123.7%  
Other income Rs m3,447383 899.3%   
Total revenues Rs m81,12263,201 128.4%   
Gross profit Rs m23,6917,317 323.8%  
Depreciation Rs m3,4325,540 61.9%   
Interest Rs m201,882 1.0%   
Profit before tax Rs m23,686278 8,526.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,453927 588.4%   
Profit after tax Rs m18,234-649 -2,810.3%  
Gross profit margin %30.511.6 261.9%  
Effective tax rate %23.0333.5 6.9%   
Net profit margin %23.5-1.0 -2,272.8%  
BALANCE SHEET DATA
Current assets Rs m97,43737,624 259.0%   
Current liabilities Rs m15,33117,724 86.5%   
Net working cap to sales %105.731.7 333.7%  
Current ratio x6.42.1 299.4%  
Inventory Days Days825 34.2%  
Debtors Days Days84256 1,508.1%  
Net fixed assets Rs m51,12871,668 71.3%   
Share capital Rs m531159 333.7%   
"Free" reserves Rs m127,14053,772 236.4%   
Net worth Rs m127,67153,931 236.7%   
Long term debt Rs m031,104 0.0%   
Total assets Rs m148,565109,292 135.9%  
Interest coverage x1,209.51.1 105,390.9%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x0.50.6 91.0%   
Return on assets %12.31.1 1,088.9%  
Return on equity %14.3-1.2 -1,187.1%  
Return on capital %18.62.5 731.1%  
Exports to sales %85.70-   
Imports to sales %19.84.1 485.0%   
Exports (fob) Rs m66,537NA-   
Imports (cif) Rs m15,3782,564 599.8%   
Fx inflow Rs m66,5377,100 937.2%   
Fx outflow Rs m15,7152,564 612.9%   
Net fx Rs m50,8224,536 1,120.5%   
CASH FLOW
From Operations Rs m24,5976,607 372.3%  
From Investments Rs m-27,076-5,444 497.3%  
From Financial Activity Rs m-7,972-1,567 508.8%  
Net Cashflow Rs m-10,451301 -3,472.0%  

Share Holding

Indian Promoters % 51.9 47.4 109.6%  
Foreign collaborators % 0.0 3.3 -  
Indian inst/Mut Fund % 36.7 23.2 158.5%  
FIIs % 14.9 20.3 73.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.1 49.3 97.5%  
Shareholders   354,482 86,588 409.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Divis Laboratories vs Jubilant Pharmova

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Divis Laboratories vs Jubilant Pharmova Share Price Performance

Period Divis Laboratories Jubilant Pharmova S&P BSE HEALTHCARE
1-Day 2.14% -0.54% 1.18%
1-Month -2.15% 2.20% -0.75%
1-Year 22.51% 109.28% 61.82%
3-Year CAGR -1.38% -6.79% 18.16%
5-Year CAGR 15.77% -2.78% 19.79%

* Compound Annual Growth Rate

Here are more details on the Divis Laboratories share price and the Jubilant Pharmova share price.

Moving on to shareholding structures...

The promoters of Divis Laboratories hold a 51.9% stake in the company. In case of Jubilant Pharmova the stake stands at 50.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Divis Laboratories and the shareholding pattern of Jubilant Pharmova.

Finally, a word on dividends...

In the most recent financial year, Divis Laboratories paid a dividend of Rs 30.0 per share. This amounted to a Dividend Payout ratio of 43.7%.

Jubilant Pharmova paid Rs 5.0, and its dividend payout ratio stood at -122.7%.

You may visit here to review the dividend history of Divis Laboratories, and the dividend history of Jubilant Pharmova.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.